Neogen Corp
NEOG4.650USD
-0.045-0.96%
Close 07/31, 16:00（ET）Quotes delayed by 15 min
1.01BMarket Cap
LossP/E TTM
More Details of Neogen Corp Company
Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
Company Info
Ticker SymbolNEOG
Company nameNeogen Corp
IPO dateAug 23, 1989
Founded at1981
CEOMr. John Edward Adent
Number of employees- -
Security typeOrdinary Share
Fiscal year-endAug 23
Address620 Lesher Pl
CityLANSING
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code48912
Phone15173729200
Websitehttps://www.neogen.com/
Ticker SymbolNEOG
IPO dateAug 23, 1989
Founded at1981
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. John Edward Adent
Mr. John Edward Adent
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.28K
+0.78%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
124.19K
+73.77%
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
90.47K
+255.16%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
80.44K
+118.27%
Dr. William T. (Bill) Boehm, Ph.D.
Dr. William T. (Bill) Boehm, Ph.D.
Independent Director
Independent Director
35.59K
+16.34%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
27.99K
+133.42%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
13.24K
+77.20%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
12.78K
+46.92%
Ms. Andrea F. Wainer
Ms. Andrea F. Wainer
Independent Director
Independent Director
6.09K
--
Mr. Thierry Bernard
Mr. Thierry Bernard
Independent Director
Independent Director
5.62K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John Edward Adent
Mr. John Edward Adent
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.28K
+0.78%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
124.19K
+73.77%
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
90.47K
+255.16%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
80.44K
+118.27%
Dr. William T. (Bill) Boehm, Ph.D.
Dr. William T. (Bill) Boehm, Ph.D.
Independent Director
Independent Director
35.59K
+16.34%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
27.99K
+133.42%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Culture Media & Other
77.74M
35.18%
Bacterial & General Sanitation
39.88M
18.05%
Rodenticides, Insecticides & Disinfectants
35.64M
16.13%
Genomics Services
22.70M
10.27%
Natural Toxins, Allergens & Drug Residues
17.59M
7.96%
Other
27.41M
12.41%
By RegionUSD
Name
Revenue
Proportion
Domestic
115.36M
52.21%
International
105.61M
47.79%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Culture Media & Other
77.74M
35.18%
Bacterial & General Sanitation
39.88M
18.05%
Rodenticides, Insecticides & Disinfectants
35.64M
16.13%
Genomics Services
22.70M
10.27%
Natural Toxins, Allergens & Drug Residues
17.59M
7.96%
Other
27.41M
12.41%
Shareholding Stats
Updated: 22 hours ago
Updated: 22 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.19%
The Vanguard Group, Inc.
10.83%
William Blair Investment Management, LLC
4.33%
Baillie Gifford & Co.
4.22%
Gates Capital Management, Inc.
4.22%
Other
63.21%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.19%
The Vanguard Group, Inc.
10.83%
William Blair Investment Management, LLC
4.33%
Baillie Gifford & Co.
4.22%
Gates Capital Management, Inc.
4.22%
Other
63.21%
Shareholder Types
Shareholders
Proportion
Investment Advisor
64.46%
Investment Advisor/Hedge Fund
43.57%
Hedge Fund
6.03%
Sovereign Wealth Fund
4.26%
Research Firm
3.39%
Pension Fund
1.74%
Bank and Trust
1.03%
Individual Investor
0.41%
Private Equity
0.31%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
712
280.17M
129.09%
-8.82M
2025Q1
753
280.62M
129.30%
-9.42M
2024Q4
764
265.86M
122.55%
-15.84M
2024Q3
778
258.29M
119.19%
-21.39M
2024Q2
791
255.45M
117.89%
-8.15M
2024Q1
783
241.86M
111.66%
-5.94M
2023Q4
783
234.38M
108.27%
-1.28M
2023Q3
770
225.33M
104.20%
-18.20M
2023Q2
761
232.20M
107.41%
-2.78M
2023Q1
759
225.00M
104.19%
-1.65M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
28.62M
13.19%
+5.44M
+23.46%
Mar 31, 2025
The Vanguard Group, Inc.
23.51M
10.83%
+1.91M
+8.86%
Mar 31, 2025
William Blair Investment Management, LLC
13.56M
6.25%
-787.83K
-5.49%
Mar 31, 2025
Baillie Gifford & Co.
9.16M
4.22%
-590.13K
-6.05%
Mar 31, 2025
Gates Capital Management, Inc.
9.16M
4.22%
+9.16M
--
Mar 31, 2025
Norges Bank Investment Management (NBIM)
14.81M
6.82%
-2.67M
-15.27%
Mar 31, 2025
State Street Global Advisors (US)
8.61M
3.97%
+282.73K
+3.40%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
8.46M
3.9%
+1.34M
+18.89%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
8.44M
3.89%
+1.50M
+21.56%
Mar 31, 2025
Mackenzie Investments
7.76M
3.57%
-67.86K
-0.87%
Mar 31, 2025
View more
Related ETFs
Updated: Sun, Jul 6
Updated: Sun, Jul 6
Name
Proportion
SPDR S&P Health Care Equipment ETF
1.51%
Invesco S&P SmallCap Health Care ETF
0.83%
iShares Emergent Food and AgTech Multisector ETF
0.62%
Federated Hermes MDT Small Cap Core ETF
0.28%
VanEck Agribusiness ETF
0.26%
WisdomTree US SmallCap Quality Growth Fund
0.22%
Invesco S&P SmallCap 600 Pure Value ETF
0.22%
Amplify Etho Climate Leadership U.S. ETF
0.22%
First Trust Multi-Manager Small Cap Opportunities ETF
0.18%
ProShares MSCI Transformational Changes ETF
0.17%
View more
SPDR S&P Health Care Equipment ETF
Proportion1.51%
Invesco S&P SmallCap Health Care ETF
Proportion0.83%
iShares Emergent Food and AgTech Multisector ETF
Proportion0.62%
Federated Hermes MDT Small Cap Core ETF
Proportion0.28%
VanEck Agribusiness ETF
Proportion0.26%
WisdomTree US SmallCap Quality Growth Fund
Proportion0.22%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.22%
Amplify Etho Climate Leadership U.S. ETF
Proportion0.22%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion0.18%
ProShares MSCI Transformational Changes ETF
Proportion0.17%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
May 12, 2021
Split
1>2
Date
Type
Ratio
May 12, 2021
Split
1>2
